Dexcom's Stelo: Revolutionizing Blood Sugar Monitoring with Over-the-Counter Access
Revolutionizing Blood Sugar Monitoring
Dexcom, a leader in continuous glucose monitoring technology, has recently launched Stelo, the first over-the-counter wearable glucose biosensor. This significant milestone comes after FDA approval in March. Now, individuals managing diabetes can effortlessly monitor their blood sugar levels without needing a prescription.
Key Features of Stelo
- Real-time glucose readings
- Over-the-counter accessibility
- User-friendly interface
- Compact and wearable design
Impact on Diabetes Management
This innovative product is expected to change how individuals manage their diabetes, offering an accessible solution that fits seamlessly into daily life. With the launch of Stelo, Dexcom reinforces its commitment to improving health outcomes through technology.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.